CEO, Board Member, Chairman
2024-08-13–present
Board Member
ENDRA Life Sciences Inc. (NDRA)Chairman
ENDRA Life Sciences Inc. (NDRA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Alexander Tokman is recorded as CEO, Board Member and Chairman at ENDRA Life Sciences Inc. (NDRA). ENDRA Life Sciences Inc. reported in an 8-K filed December 15, 2025 that Alexander Tokman was appointed director, effective December 9, 2025. ENDRA Life Sciences Inc. reported in an 8-K filed August 13, 2024 that Alexander Tokman was appointed Chairman, effective August 13, 2024. ENDRA Life Sciences Inc. reported in an 8-K filed August 13, 2024 that Alexander Tokman was appointed acting Chief Executive Officer, effective August 13, 2024. The proxy statement of ENDRA Life Sciences Inc. reports total compensation of $215,185 for Alexander Tokman in fiscal 2024, including a base salary of $114,231. Alexander Tokman has spoken on 1 earnings call across 1 company, most recently for ENDRA Life Sciences Inc. on August 23, 2024.
“The Company’s stockholders elected the four directors nominated by the Company’s Board of Directors to serve until the next annual meeting of stockholders and the election of their successors”
“Effective August 13, 2024, the Board appointed Alexander Tokman as the Company’s acting Chief Executive Officer and Chairman.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2025-12-09–present
2024-08-13–present
Start not stated–present
Recorded roles and call appearances connecting this person to public companies.
CEO, Board Member, Chairman
2024-08-13–present
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | ENDRA Life Sciences Inc. (NDRA) | Chief Executive Officer (since August 13, 2024) | $114,231 | $215,185 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.